Navigation Links
BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
Date:11/13/2008

LAVAL, QC, Nov. 13 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces today that it has received approval from the NASDAQ Listing Qualifications Staff of The NASDAQ Stock Market LLC (the "Staff") to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market. The transfer will be effective as of the opening of the market on Friday, November 14, 2008. The Company will continue to trade on NASDAQ under the symbol "BLUS".

The NASDAQ Capital Market is a continuous trading market that operates in the same manner as The NASDAQ Global Market. The NASDAQ Capital Market includes the securities of approximately 450 companies. All companies listed on The NASDAQ Capital Market must meet certain financial requirements and adhere to NASDAQ's corporate governance standards.

The listing transfer was sought by the Company in response to prior correspondence received from the Staff regarding compliance with The NASDAQ Global Market's requirements for the minimum market value of the Company's listed securities, as disclosed in the Company's press release dated October 15, 2008.

The Company's common stock is also listed on the Toronto Stock Exchange, which listing is not affected by the transfer from The NASDAQ Global Market to The NASDAQ Capital Market.

About BELLUS Health

BELLUS Health is a global health company focused on the development and commercialization of products to provide innovative health solutions to address critical unmet needs.

To Contact BELLUS Health

For additional information on BELLUS Health and its drug development programs, please call the Canada and United States toll-free number 1 877 680 4500 or visit the Web Site at http://www.bellushealth.com.

Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof
'/>"/>

SOURCE BELLUS Health Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. BELLUS HEALTH reports results for first quarter of fiscal 2008
3. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
4. BELLUS Health announces closing of Innodia acquisition
5. BELLUS Health provides update on activities
6. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
7. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
8. Penn study finds pro-death proteins required to regulate healthy immune function
9. UCLA researchers identify markers that may predict diabetes in still-healthy people
10. Air pollution linked to cardiovascular risk indices in healthy young adults
11. More proof needed of safety and quality of electronic personal health records
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...irstCall/ -- Cardinal Health today,announced it e...sults for its,fiscal second quarter, but provided...ause of a deferral in hospital capital spending af.... , Non-GAAP diluted EPS from continuing op...er, ended Dec. 31, 2008, is anticipated to be at l...
(Date:1/8/2009)...0 million Americans in the U.S. are,functionally ...ikely than,average to grow up illiterate(1). The ...to read is more crucial than ever. President-Elect...y childhood education in the United States.,WordW...ndard for how best to,use interactive media in ea...
(Date:1/8/2009)...application is accessible to clinicians throughout...ent system. , Redwood Cit... Inc. , a leader in advanced visualization and ana...ced that it has received 510(k) clearance from the...T brain perfusion application. , , , ,The brain p...
(Date:1/7/2009)...reatic cancer is discovered, it is often late stag...) and survival rates are low. Dr. Aaron Chevinsky..., liver and gastrointestinal (GI) cancers wasn,t s...dbreaking team approach to improve communication a.... , Morristown, NJ (PRW...
Breaking Medicine News(10 mins):Health News:Cardinal Health Updates FY09 Outlook 2Health News:Cardinal Health Updates FY09 Outlook 3Health News:Cardinal Health Updates FY09 Outlook 4Health News:Cardinal Health Updates FY09 Outlook 5Health News:U.S. Department of Education-Funded Study Demonstrates, WordWorld, PBS KIDS(R) Television Series Works as Critical Early Literacy Tool 2Health News:U.S. Department of Education-Funded Study Demonstrates, WordWorld, PBS KIDS(R) Television Series Works as Critical Early Literacy Tool 3Health News:U.S. Department of Education-Funded Study Demonstrates, WordWorld, PBS KIDS(R) Television Series Works as Critical Early Literacy Tool 4Health News:Ziosoft Receives FDA Clearance for CT Brain Perfusion Application 2Health News:Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes 2
...n-making body of the All India Institute of Medica.... Venugopal from the post following whichemergency...to a standstill. The decision was taken during a t...-members governing body, headed by Health Minister...
...e a link between the oft occurring infections in c...al records of more than 4000 patients, below the a...tish researchers .It was observed that those who h...fections showed a 6 to 7 % tendency of developing ...
...he Monash Institute of Medical Research (MIMR) hav...ctroscopy, which allowed scientists// to monitor p...rst of its kind in Australia, helped doctors to mo...ting BP and brain oxygen levels of a preterm babie...
...e of a Palestinian doctor and five Bulgarian nurse...en with HIV has resumed //in the Libyan capital, T...eir infected children as prosecution witnesses in ...ve Bulgarian women as the nurses who knowingly inf...
Other Medicine News:Health News:Preterm Babies Benefited from a New NI Spectroscopy 2
(Date:1/7/2009)...ease , , WHITE PLAINS, N.Y., Jan. 7 /PRNewswire...that the decades-long rise in the United States pr...han ever at increased risk of death and disability...3,000 babies were born too soon in 2006, according...ch today released "Births: Final data for 2006," N...
(Date:1/7/2009)...ewswire/ -- Circassia Ltd, a specialty,biopharmac...re, today,announced that following successful cli...e(R) anti-allergy technology, the company has now ... II clinical trial in cat allergy. The,study, whi...ts with confirmed,cat allergies, and all the part...
(Date:1/6/2009)...wire/ -- The Michael J. Fox Foundation awarded a t...ch teams for pre-clinical research on potential ne...unding was awarded under the Foundation,s Therape... launched in 2006, supports and bolsters industry-...part of MJFF,s focus on ,de-risking, preclinical...
(Date:1/6/2009)...swire-FirstCall/ -- , - Early Renewal of th...ember 2011 , - Expansion of the Scope of th...Ophthalmology , - Revised Commercial Terms ...o a Third Party , ExonHit Therapeutics (A...of its existing drug discovery collaboration with ...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 1Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 2Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 3Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 4Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 5Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 6Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 7Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 8Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 9Uroplasty Reports Record Sales for Third Fiscal Quarter and Nine Months Ended December 31 2007 3157 10Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections 1348 1Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections 1348 2Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections 1348 3Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 11463 1Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 11463 2Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 11463 3Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade 11463 4Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2008 Financial Results on Tuesday February 12 2008 at 5 3A00 P M EST 11461 1Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2008 Financial Results on Tuesday February 12 2008 at 5 3A00 P M EST 11461 2
...-(BUSINESS WIRE)--May 29, 2007 - Mitopharm Corpora...s of a research paper,where Professor Dr. Robert K...B, the precursor of (-) Schisandrin B - a novel,di... a research paper entitled "SCHISANDRIN B PROTECTS... ENHANCING MYOCARDIAL,GLUTATHIONE ANTIOXIDANT STAT...
...story Highlighted in AACR Cancer Journal , AUSTIN,...erapeutics, Inc. (NASDAQ:INGN) announced today the...cal benefit of its lead product,Advexin in a patie...i-Fraumeni Syndrome (LFS), a genetic disorder char...suppressor gene. This is the,first reported treatm...
Other Medicine Technology:Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 2Investigation Findings, Corroborated by Empirical Evidence of the,Schisandra Berry as Cardio-Tonic in Traditional Chinese Medicine,for Hundreds of Years, Support the Use of Schisandrin B in the,Prevention and Treatment of IHD 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 2Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 3Introgen's Advexin Demonstrates Clinical Benefit in Inherited,Cancer 4
...The Trinity Biotech Captia Borrelia burgdorferi (B... Assay (ELISA) is intended for the qualitative pre...antibodies to Borrelia burgdorferi in human serum....signs and symptoms that are consistent with Lyme d...
SOFSILK™ BLACK Coated Braided Silk Suture in various sizes.
Surgitie&trade Single Use Ligating Loops with Delivery System
Surgitie&trade Single Use Ligating Loops with Delivery System
Medicine Products: